MỘT SỐ ĐẶC ĐIỂM Ở BỆNH NHÂN VIÊM BỜ MI ĐƯỢC ĐIỀU TRỊ BẰNG OCUSOFT TẠI BỆNH VIỆN MẮT NGHỆ AN

Abstract

Objectives: Determine some characteristics of Demodex blepharitis patients treated with Ocusoft. Subjects and methods: Prospective corelation study, 102 patient's eyes test found 1 Demodex on eyelash follicles treated with Ocusoft at Nghe An Eye Hospital from July 2021 to July 2022. Results: Patients in the study group came from rural areas (64.7%), more than patients from cities (35.3%), the difference was statistically significant with p<0.05. Only 9 patients were reported to have been treated for blepharitis (17.6%). The most common functional symptoms in the study group of patients were eyelid itching (100%), eyelid swelling (98%), dry eye feeling (96.1%). The second most common causes were the groups of symptoms of lacrimation and eyelid swelling (66.7% and 54.9%, respectively). Less common symptoms were eyelid burning sensation and eyelid sticky sensation (37.3% and 33.3%). The most common physical symptoms in the study group were blepharospasm and ciliary cystic dandruff (98%). In the group of patients, there was mainly a state of tear insufficiency with the Schimer I test <10mm, accounting for 56.9%. The number of patients with BUT test results <10 seconds is the main dry eye (84.3%). Level 2 ocular surface lesions accounted for the highest rate (47.1%), then to grade 1 and 3 (21.5% and 19.6 respectively. The highest OSDI score was 36, the lowest was 8. Most of the study group had visual acuity in the group ≥5/10 and from 2/10-5/10, the average number of Demodex was 8.02±2.43 individuals/microenvironment.